Literature DB >> 17147691

Standardized nonculture techniques recommended for European reference laboratories.

Andrew J Fox1, Muhamed-Kheir Taha, Ulrich Vogel.   

Abstract

Culture-confirmed diagnosis of meningococcal invasive infections is often hindered by early antibiotic treatment. Nonculture molecular standardized methods are now essential tools for the immediate management of meningococcal infections. The European Monitoring Group on Meningococci (EMGM) recommends the following measures. (1) The implementation of standardized protocols of extraction methods for DNA isolation from clinical specimens for PCR-based identification and genogrouping of Neisseria meningitidis. (2) The use of molecular approaches (sequencing of target genes) for the determination of meningococcal susceptibility to antibiotics, such as sequencing of penA and rpoB genes for susceptibility to penicillin G and rifampicin, respectively. (3) The use of nonculture strain characterization by multilocus sequence typing (MLST) and sequence typing of porA and fetA. These approaches can be implemented either by individual reference laboratories or through collaboration and referral between centres.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17147691     DOI: 10.1111/j.1574-6976.2006.00048.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  8 in total

1.  Multiple nucleotide substitutions in the Neisseria meningitidis serogroup C ctrA gene cause false-negative detection by real-time PCR.

Authors:  Francesca Cavrini; Giovanna Liguori; Arianna Andreoli; Vittorio Sambri
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

2.  Pathophysiology and treatment of bacterial meningitis.

Authors:  Olaf Hoffman; R Joerg Weber
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

3.  Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP.

Authors:  Jay Lucidarme; Lynne S Newbold; Jamie Findlow; Stefanie Gilchrist; Stephen J Gray; Anthony D Carr; James Hewitt; Edward B Kaczmarski; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2010-12-01

4.  Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context.

Authors:  Anand P Dubey; Rashna Dass Hazarika; Veronique Abitbol; Shafi Kolhapure; Someya Agrawal
Journal:  Hum Vaccin Immunother       Date:  2021-02-19       Impact factor: 3.452

5.  Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique.

Authors:  Ana Belén Ibarz-Pavón; Luis Morais; Betuel Sigaúque; Inacio Mandomando; Quique Bassat; Ariel Nhacolo; Llorenç Quintó; Montse Soriano-Gabarró; Pedro L Alonso; Anna Roca
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

6.  Antigen sequence typing of outer membrane protein (fetA) gene of Neisseria meningitidis serogroup A from Delhi & adjoining areas.

Authors:  S Dwivedi; B K Das; A Kapil; S Sood; R Chaudhry; S Gupta; M Deb; D Nair; S Aneja
Journal:  Indian J Med Res       Date:  2014-12       Impact factor: 2.375

Review 7.  Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease.

Authors:  J A Vázquez; M K Taha; J Findlow; S Gupta; R Borrow
Journal:  Epidemiol Infect       Date:  2016-06-30       Impact factor: 2.451

8.  Mobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin.

Authors:  Berthe-Marie Njanpop-Lafourcade; Stéphane Hugonnet; Honoré Djogbe; Agbenoko Kodjo; Adèle Kacou N'douba; Muhamed-Kheir Taha; Philippe Stoeckel; Bradford D Gessner
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.